AC
NPCE icon

Armistice Capital’s Neuropace NPCE Stock Holding History

Armistice Capital’s Portfolio NPCE Stock Details NPCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11M Hold
692,000
– – 0.13% 104
2026
Q1 		$9.1M Sell
692,000
-100,000
-13% -$1.5M 0.16% 96
2025
Q4 		$12.2M Sell
792,000
-506,000
-39% -$6.77M 0.15% 94
2025
Q3 		$13.4M Buy
1,298,000
+145,665
+13% +$1.37M 0.2% 76
2025
Q2 		$12.8M Sell
1,152,335
-1,279
-0.1% -$16K 0.22% 57
2025
Q1 		$14.2M Buy
1,153,614
+561,000
+95% +$7.02M 0.21% 84
2024
Q4 		$6.63M Buy
592,614
+112,614
+23% +$979K 0.09% 115
2024
Q3 		$3.35M Buy
+480,000
New +$3.51M 0.05% 140

Other funds holding NPCE

PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Armistice Capital's NPCE Position: Q2 2026 in Review

Armistice Capital held its Neuropace (NPCE) position steady in Q2 2026 at 692,000 shares worth $11M. The position accounts for 0.13% of the portfolio, ranked #104.

Armistice Capital first reported a position in NPCE in Q3 2024 and has held it in 8 quarters since. The position peaked at $14.2M in Q1 2025. 113 funds tracked by Wall St. Rank hold NPCE as of Q2 2026.

  • Armistice Capital held 692,000 shares of Neuropace worth $11M as of Q2 2026.
  • Armistice Capital left its Neuropace share count unchanged in Q2 2026.
  • Neuropace made up 0.13% of Armistice Capital's portfolio in Q2 2026, its #104 holding.
  • Armistice Capital first reported a position in Neuropace in Q3 2024 and has held it in 8 quarters since.
  • Armistice Capital's Neuropace position peaked at $14.2M in Q1 2025.
  • 113 funds tracked by Wall St. Rank held Neuropace as of Q2 2026.

Based on Armistice Capital's 13F filing for Q2 2026, filed 14 Aug 2026.